Search results
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients with Pathologic Nipple Discharge
… The primary goal is to determine whether retrieval of a solitary papilloma can … Efficacy of Ductoscopic Papilloma Extraction in Patients with Pathologic Nipple Discharge …
Last Modified:
An Open-Label, Multicenter Phase Ib Study of The Safety and Tolerability of Atezolizumab (Anti-PD-L1 Antibody) Administered in Combination With Bevacizumab and/or Other Treatments in Patients With Solid Tumors
… This purpose of this study is to evaluate the safety and tolerability of study drug atezolizumab when administered with bevacizumab and FOLFOX in patients with gastric cancer. This study will also evaluate the safety … (Anti-PD-L1 Antibody) Administered in Combination With Bevacizumab and/or Other Treatments in Patients With …
Last Modified:
General Surgery Activities for 1st & 2nd Year Medical Students
… Students who want to get involved with surgery before their major clinical year have several options. For more information, please contact: Doris Leddy Surgery … Kidney/Liver) The Transplant Procurement Program is a unique and exciting opportunity for first-year …
Last Modified:
Columbia’s Department of Surgery Establishes the Newmyer Family Fellowship for Innovation in Surgery
… at Columbia University Irving Medical Center (CUIMC) is very pleased to announce a gift to create the Newmyer Family Fellowship for Innovation in Surgery, with gratitude to donor Arthur G. … of Surgery Establishes the Newmyer Family Fellowship for Innovation in Surgery …
Last Modified:
Looking for patient to enroll in Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
… If not known before, Pancreatic cancer is the third-most common cause of cancer-related death in the … removal of the pancreas is considered the only chance for cure, but many patients are not able to have surgery due … In this new study, the Pancreas Center has partnered with a national cooperative clinical trial group (Alliance …
Last Modified:
A randomized, double-blind, placebo-controlled, phase II study of sorafenib in subjects with hepatopulmonary syndrome
… he main purpose of this clinical trial is to determine the safety and effects of the study drug, sorafenib, in adults diagnosed with hepatopulmonary syndrome (HPS). The study will evaluate how well the drug is tolerated and its effect on the level of oxygen in the …
Last Modified:
A Phase Ib/II Open Label Umbrella Study Evaluating Immunotherapy Based Combinations with Metastatic Pancreas Adenocarcinoma.
… This study is a open-label, multicenter, randomized study designed to … immunotherapy-based treatment combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC). … Umbrella Study Evaluating Immunotherapy Based Combinations with Metastatic Pancreas Adenocarcinoma. …
Last Modified:
Success Story from The Center for Metabolic and Weight Loss Surgery
… and vitality. Read more » Learn more about our Center for Metabolic and Weight Loss Surgery here . To refer a … Success Story from The Center for Metabolic and Weight Loss Surgery …
Last Modified:
Phase II Open-Label, Single-Center Study Evaluating Safety and Efficacy of Pembrolizumab Following Induction with the Hypomethylating Agent Azacitidine in Patients with Advanced Pancreatic Cancer After Failure of First-Line Therapy
… Safety and Efficacy of Pembrolizumab Following Induction with the Hypomethylating Agent Azacitidine in Patients with Advanced Pancreatic Cancer After Failure of First-Line …
Last Modified:
Thank you for your interest in Columbia’s Data & Heart Surgery Report.
… Thank you for your interest in Columbia’s Data & Heart Surgery Report. …
Last Modified:
A Phase I Study of IHD305 in Patients with Advanced Malignancies that Harbor IDH1R132 Mutations
… The primary purpose of this research study is to assess how safe and well tolerated the study drug, IDH305, is when given to patients who have advanced tumors that … maintaining cancer. The hypothesis of this research study is inhibiting the mutant IDH1 mutation in these tumors will …
Last Modified:
Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety, and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy (STOP-HE)
… The purpose of this study is to determine whether ornithine phenylacetate can speed … OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy (STOP-HE) …
Last Modified:
A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination with Ipilimumab in Patients with B7-H3-Expressing Melanoma, Squamous Cell Cancer of the Head and Neck or Non Small Cell Lung Cancer
… The purpose of this study is to test the safety, tolerability, and most effective dose of MGA271 in combination with ipilimumab (also called Yervoy®). MGA271 has not been … Administration (FDA). Ipilimumab is approved by the FDA for use in melanoma patients, but it is experimental for …
Last Modified:
Dr. James Lee honored with the Science Leadership Award at the SDHB Pheo-Para Coalition Gala
… The Columbia Thyroid Center is proud to announce that Dr. James Lee , Co-Director , was honored at the SDHB Pheo-Para Coalition Gala with the Science Leadership Award on April 20th, 2017. There … event. Dr. Lee expressed his thanks towards the Coalition for this significant honor and for the program's ongoing …
Last Modified: